과제정보
연구 과제 주관 기관 : Council of Scientific and Industrial Research (CSIR)
참고문헌
- ABadie B, Schartner J (2001). Role of microglia in glioma biology. Microsc Res Tech, 54, 106-11. https://doi.org/10.1002/jemt.1125
- Barchana M, Margaliot M, Liphshitz I (2012). Changes in brain glioma incidence and laterality correlates with use of mobile phones . a nationwide population based study in Israel. Asian Pac J Cancer Prev, 13, 5857-63. https://doi.org/10.7314/APJCP.2012.13.11.5857
- Bhattacharjee M, Bose I, Sarkar P, et al (2006). A sequential scanning of the immune efficacy in astrocytoma (grade i . grade iii), meningioma and secondary glioma patients with and without therapeutic scheduling. Cancer Invest, 24, 502-13. https://doi.org/10.1080/07357900600814839
- CBTRUS statistical report (2011). Primary brain and central nervous system tumors diagnosed in the United States in 2004-2007. source: central brain tumour registry of the united states, hinsdale, IL. Website: www.cbtrus.org.
- Chen WJ, He DS, Tang RX, et al (2015). Ki-67 is a valuable prognostic factor in gliomas: evidence from systematic review and meta-analysis. Asian Pac J Cancer Prev, 16, 411-20. https://doi.org/10.7314/APJCP.2015.16.2.411
- Chen X, Zhang L, Zhang IY, et al (2014). RAGE Expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Res, 74, 7285-97. https://doi.org/10.1158/0008-5472.CAN-14-1240
- Coniglio SJ, Segall JE (2013). Molecular mechanism of microglia stimulated glioma invasion. Matrix Biol, 32, 372-80. https://doi.org/10.1016/j.matbio.2013.07.008
- Das BR, Tangri R, Ahmad F, et al (2013). Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in indian patients. Asian Pac J Cancer Prev, 14, 7261-4. https://doi.org/10.7314/APJCP.2013.14.12.7261
- Dix AR, Brooks WH, Roszman TL, et al (1999). Immune defects observed in patients with primary malignant brain tumours. J Neuroimmunol, 100, 216-32. https://doi.org/10.1016/S0165-5728(99)00203-9
- Efird JT (2011). Epidemiology of glioma. in 'glioma: exploring its biology and practical relevance', Ed. Ghosh A. InTech, Rijeka, Croatia, 3-24.
- Elliott LH, Brooks WH, Roszman TL (1990). Inability of mitogen activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors. J Clin Invest, 86, 80-6. https://doi.org/10.1172/JCI114719
- Ghosh A, Chaudhuri S (2010). Microglial Action in Glioma: A Boon Turns Bane. Immunol Lett, 131, 3-9. https://doi.org/10.1016/j.imlet.2010.03.003
- Ghosh A, Sarkar S, Dutta S, et al (2004). The First Crosssectional survey on intracranial malignancy in Kolkata, India: reflection of the state of art in southern west bengal. Asian Pac J Cancer Prev, 5, 259-67.
- Ghosh P, Mukherjee N, Ghosh K, et al (2015). Prospective microglia and brain macrophage distribution pattern in normal rat brain shows age sensitive dispersal and stabilization with development. Ind J Exp Biol, 53, 561-7.
- Khan MK, Hunter GK, Vogelbaum M, et al (2009). Evidencebased adjuvant therapy for gliomas: current concepts and newer developments. Ind J Cancer, 46, 96-107. https://doi.org/10.4103/0019-509X.49147
- Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
- Markovic DS, Vinnakota K, Chirasani S, et al (2009). Glioma induce and exploit microglial MT1-MMP expression for tumor expansion. PNAS, 106, 12530-5. https://doi.org/10.1073/pnas.0804273106
- Morioka T, Baba T, Black KL, et al (1992). Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumours. Neurosurgery, 30, 891-6.
- Ng K, Kesari S, Carter B, et al (2011). Molecular etiology of glioblastomas: implication of genomic profiling from the cancer genome atlas project. in 'glioma: exploring its biology and practical relevance', Ed. Ghosh A. InTech, Rijeka, Croatia, 25-36.
- Penfield W, Cone W (1937). Neuroglia and microglia (the metallic methods). In: Handbook of Microscopical Techniques, Eds. McClung CE, Paul B. Hoeber Inc, New York, 489-521.
- Preusser M, de Ribaupierre S, Wohrer A, et al (2011). Current concepts and management of glioblastoma. Ann Neurol, 70, 9-21; https://doi.org/10.1002/ana.22425
- Roggendorf W, Strupp S, Paulus W, et al (1996). Distribution and characterization of microglia/macrophages in human brain tumours. Acta Neuropathol, 92, 288-93. https://doi.org/10.1007/s004010050520
- Sarkar S, Doring A, Zemp FJ, et al (2014). Therapeutic activation of macrophages and microglia to suppress brain tumorinitiating cells. Nat Neurosci, 17, 46-55. https://doi.org/10.1038/nn.3597
- Szulzewsky F, Pelz A, Feng X, et al (2015). Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express gpnmb and spp1. PLoS ONE, 10.
- Trabelsi S, Brahim DH, Ladib M, et al (2014). Glioma epidemiology in the Central Tunisian Population: 1993-2012. Asian Pac J Cancer Prev, 15, 8753-7. https://doi.org/10.7314/APJCP.2014.15.20.8753
- Wei J, Gabrusiewicz K, Heimberger A (2013). The controversial role of microglia in malignant gliomas. Clin Dev Immunol, 2013, 285246.
- Xavier-Magalhaes A, Nandhabalan M, Jones C, et al (2013). Molecular prognostic factors in glioblastoma: state of the art and future challenges. CNS Oncol, 2, 495-510. https://doi.org/10.2217/cns.13.48
- Ye XZ, Xu SL, Xin YH, et al (2012). Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol, 189, 444-53. https://doi.org/10.4049/jimmunol.1103248